We use cookies to understand how visitors search for and consume the information we provide, so that we can improve their experience. By browsing this website, you indicate your acceptance of the use of such cookiesAcceptRead more

Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • en
  • You are viewing the website in Français fr
Search the site
  • Whowe are
    • Company
    • Team
    • Collaborations
  • Our products& pipeline
    • Diseases we target
    • GS010 for LHON
    • GS030 for Retinitis Pigmentosa
    • GS030 for Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
  • Investors& media
    • Company Overview
    • Communiqués de presse
    • Events & presentations
    • Stock information
    • Governance
    • Documentation

Restez informé

Inscrivez-vous à notre newsletter pour recevoir les dernières informations de GenSight Biologics

Fields marked with an * are required
© 2018 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
Retourner en haut de la page